-transparent.png){kind=logo}
Hirudin causes a rapid inhibition of blood coagulation as shown by in vitro and in vivo experiments in the dog. The substance appears to be a rather specific antithrombin. Its inhibitory action is linearly dose related and therefore easy to control and reproduce. Side effects can be expected to be abolished after further purification of the substance.
Related Publications
T Klöss, and
W Lorenz, and
U Meyer, and
U Mittmann, and
E Neugebauer, and
W W Saggau
January 1991,
Haemostasis,
T Klöss, and
W Lorenz, and
U Meyer, and
U Mittmann, and
E Neugebauer, and
W W Saggau
July 1962,
Thrombosis et diathesis haemorrhagica,
T Klöss, and
W Lorenz, and
U Meyer, and
U Mittmann, and
E Neugebauer, and
W W Saggau
January 1990,
Advances in experimental medicine and biology,
T Klöss, and
W Lorenz, and
U Meyer, and
U Mittmann, and
E Neugebauer, and
W W Saggau
February 1991,
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
T Klöss, and
W Lorenz, and
U Meyer, and
U Mittmann, and
E Neugebauer, and
W W Saggau
September 1990,
FEBS letters,
T Klöss, and
W Lorenz, and
U Meyer, and
U Mittmann, and
E Neugebauer, and
W W Saggau
January 1984,
Haemostasis,
T Klöss, and
W Lorenz, and
U Meyer, and
U Mittmann, and
E Neugebauer, and
W W Saggau
August 1986,
Biochemistry,
T Klöss, and
W Lorenz, and
U Meyer, and
U Mittmann, and
E Neugebauer, and
W W Saggau
January 1990,
Medicina (Florence, Italy),
T Klöss, and
W Lorenz, and
U Meyer, and
U Mittmann, and
E Neugebauer, and
W W Saggau
December 1994,
Circulation,
T Klöss, and
W Lorenz, and
U Meyer, and
U Mittmann, and
E Neugebauer, and
W W Saggau
January 1993,
Advances in experimental medicine and biology,
